EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Altered hepatic metabolic landscape and insulin sensitivity in response to pulmonary tuberculosis

Mrinal K Das iD, Ben Savidge, John E Pearl, Thomas Yates, Gareth Miles, Manish Pareek, Pranabashis Haldar, Andrea M Cooper iD

PLOS Pathogens · 2024

DOI: 10.1371/journal.ppat.1012565 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Mrinal K Das und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Sciences, Leicester TB Research Group, University of Leicester, Leicester, United Kingdom. Hauptthemen laut MEDLINE: Tuberculosis, Pulmonary, Insulin Resistance, Gluconeogenesis, Liver. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Royal Society, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic inflammation triggers development of metabolic disease, and pulmonary tuberculosis (TB) generates chronic systemic inflammation. Whether TB induced-inflammation impacts metabolic organs and leads to metabolic disorder is ill defined. The liver is the master regulator of metabolism and to determine the impact of pulmonary TB on this organ we undertook an unbiased mRNA and protein analyses of the liver in mice with TB and reanalysed published data on human disease. Pulmonary TB led to upregulation of genes in the liver related to immune signalling and downregulation of genes encoding metabolic processes. In liver, IFN signalling pathway genes were upregulated and this was reflected in increased biochemical evidence of IFN signalling, including nuclear location of phosphorylated Stat-1 in hepatocytes. The liver also exhibited reduced expression of genes encoding the gluconeogenesis rate-limiting enzymes Pck1 and G6pc. Phosphorylation of CREB, a transcription factor controlling gluconeogenesis was drastically reduced in the livers of mice with pulmonary TB as was phosphorylation of other glucose metabolism-related kinases, including GSK3a, AMPK, and p42. In support of the upregulated IFN signalling being linked to the downregulated metabolic functions in the liver, we found suppression of gluconeogenic gene expression and reduced CREB phosphorylation in hepatocyte cell lines treated with interferons. The impact of reduced gluconeogenic gene expression in the liver was seen when infected mice were less able to convert pyruvate, a gluconeogenesis substrate, to the same extent as uninfected mice. Infected mice also showed evidence of reduced systemic and hepatic insulin sensitivity. Similarly, in humans with TB, we found that changes in a metabolite-based signature of insulin resistance correlates temporally with successful treatment of active TB and with progression to active TB following exposure. These data support the hypothesis that TB drives interferon-mediated alteration of hepatic metabolism resulting in reduced gluconeogenesis and drives systemic reduction of insulin sensitivity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tuberculosis, PulmonaryInsulin ResistanceGluconeogenesisLiverAnimalsMiceHumansSignal TransductionHepatocytesMice, Inbred C57BLPhosphorylationSTAT1 Transcription FactorCyclic AMP Response Element-Binding ProteinPhosphoenolpyruvate Carboxykinase (GTP)Glucose-6-PhosphataseMaleMycobacterium tuberculosisIntracellular Signaling Peptides and Proteins

Substanzen

Pck1 protein, mouseSTAT1 Transcription FactorCyclic AMP Response Element-Binding ProteinPhosphoenolpyruvate Carboxykinase (GTP)Glucose-6-PhosphataseCreb1 protein, mouseStat1 protein, mouseIntracellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Department of Respiratory Sciences, Leicester TB Research Group, University of Leicester, Leicester, United Kingdom.
  • Diabetes Research Centre, University of Leicester, Leicester, United Kingdom.
  • NIHR Leicester Biomedical Research Centre, University of Leicester and University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.
  • Leicester Cancer Research Centre, University of Leicester, Clinical Sciences Building, Leicester, United Kingdom.
  • Department of Infection and HIV Medicine, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.
  • NIHR Respiratory Biomedical Research Centre, Leicester, Glenfield Hospital, Groby Road, Leicester, United Kingdom.

ORCID-Profile: Mrinal K Das, Andrea M Cooper

Förderung

  • Wellcome Trust
  • Royal Society
  • Medical Research Council
  • Biotechnology and Biological Sciences Research Council
  • University of Leicester Microbial Sciences and Infectious Disease Centre
  • European Union
  • UKRI

Zitieren

APA

Das, M. K., Savidge, B., Pearl, J. E., Yates, T., Miles, G., Pareek, M., Haldar, P., & Cooper, A. M. (2024). Altered hepatic metabolic landscape and insulin sensitivity in response to pulmonary tuberculosis. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012565

Vancouver

Das MK, Savidge B, Pearl JE, Yates T, Miles G, Pareek M, et al. Altered hepatic metabolic landscape and insulin sensitivity in response to pulmonary tuberculosis. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1012565

BibTeX
@article{Das2024,
  author = {Das, Mrinal K and Savidge, Ben and Pearl, John E and Yates, Thomas and Miles, Gareth and Pareek, Manish and Haldar, Pranabashis and Cooper, Andrea M},
  title = {Altered hepatic metabolic landscape and insulin sensitivity in response to pulmonary tuberculosis},
  journal = {PLOS Pathogens},
  year = {2024},
  doi = {10.1371/journal.ppat.1012565}
}
Kostenlos starten →